Coral Laboratories Limited (BOM:524506)
500.00
-3.75 (-0.74%)
At close: Jun 18, 2026
Coral Laboratories Revenue
In the fiscal year ending March 31, 2026, Coral Laboratories had annual revenue of 859.00M INR, down -25.31%. Coral Laboratories had revenue of 264.79M in the quarter ending March 31, 2026, a decrease of -5.88%.
Revenue
859.00M
Revenue Growth
-25.31%
P/S Ratio
2.08
Revenue / Employee
4.36M
Employees
197
Market Cap
1.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 859.00M | -291.06M | -25.31% |
| Mar 31, 2025 | 1.15B | 313.45M | 37.47% |
| Mar 31, 2024 | 836.60M | 55.42M | 7.09% |
| Mar 31, 2023 | 781.19M | 25.08M | 3.32% |
| Mar 31, 2022 | 756.11M | -209.57M | -21.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.55B |
| Kerala Ayurveda | 1.31B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |